This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Life Sciences

Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the life sciences are changing at a remarkable rate. Deloitte LLP’s Life Sciences practice works with our clients to shape the evolution of the industry. 

Learn more about our Health Sciences practice.

More Featured insights

  • In the face of uncertainty - Redefining biopharma innovation
    A recent Deloitte study has shown that the overall rate of return on R&D investment for the 12 largest biopharmaceutical firms has dropped significantly since 2010, and the cost of developing a new medicine has risen substantially. Learn more.
  • A tall order to fill: Enrolling young adults in health insurance
    What can industry stakeholders learn from the findings of Deloitte’s 2014 survey of young adults and health insurance to help increase enrollment of this population during special enrollment in 2014 and in the 2015 open enrollment season?
  • The four dimensions of effective mHealth: People, places, payment and purpose
    The promise of mHealth is profound but, as yet, unrealized. While the tools to deliver mHealth already reside in users’ hands, how do we bridge the gap from opportunity to adoption? In order for mHealth to reach its full potential, four critical dimensions must align: people, places, payment and purpose.
  • 3D opportunity in medical technology
    Additive manufacturing capabilities align well with the needs of the medical device segment, enhancing product customization and enabling efficient, cost-effective production and delivery.
  • 2014 Global life sciences sector outlook
    The report outlines the top issues facing global life sciences stakeholders, provides a snapshot of activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2014 and beyond.

Join Our Team

Explore Health Sciences career opportunities: Experienced Hires | Students

 

Stay Updated

Subscribe to receive updates from Deloitte's Life Sciences practice:
Life Sciences Email E-mail |   Life Sciences RSS RSS ( What is RSS?) |  Life Sciences Twitter Twitter 

 

 

 

 

 

 

 

More Watch, listen and learn

  • Health Care Current
    A weekly newsletter to keep you informed and ahead.
  • A view from the Center
    Read the Center for Health Solutions blog.
  • In the news: Deloitte Health
    Straight from the headlines.
  • Navigating the rapidly evolving social media landscape in health care
    Register for the August 12 webcast.
  • Live from the Center: Are you prepared for 2015 HIX open enrollment?
    View the archived webcast.

More Dig deeper

  • ConvergeHEALTH by Deloitte
    Learn more.
  • 2014 U.S. Outlook on Life Sciences
    Challenges, trends and strategies that may shape your business.
  • Consulting offerings for the Life Sciences industry
    Helping our clients lead and shape the global marketplace.
  • Deloitte health: Resources, reform, results
    A library of resources.
  • Deloitte Center for Health Solutions
    Health care insights start with research.

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected